112 related articles for article (PubMed ID: 2208040)
1. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.
Smit VT; Fleuren GJ; van Houwelingen JC; Zegveld ST; Kuipers-Dijkshoorn NJ; Cornelisse CJ
Cancer; 1990 Oct; 66(8):1843-9. PubMed ID: 2208040
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
4. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
7. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids.
Sinton EB; Carver RK; Morgan DL; Philpott PJ; Truell JE; Riemann D; Ashton ME
Arch Pathol Lab Med; 1990 Feb; 114(2):188-94. PubMed ID: 2302036
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
10. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear DNA assay in gynecologic malignant tumors and its clinical significance].
Cheng X
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):353-5. PubMed ID: 1782848
[TBL] [Abstract][Full Text] [Related]
15. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
Roush GR; el-Naggar AK; Abdul-Karim FW
Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
[TBL] [Abstract][Full Text] [Related]
16. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
[TBL] [Abstract][Full Text] [Related]
18. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
19. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA ploidy analysis of feline mammary tumors.
Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
